SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
¶
– Release Delayed to: 7/8/15 ·As Of Filer Filing For·On·As Docs:Size Issuer Agent 5/20/15 Innovator ETFs Trust II N-1A/A¶ 4:1.0M Kelvyn Press Inc/FA → Elkhorn S&P 500 Capital Expenditures Portfolio ⇒ CAPX |
Document/Exhibit Description Pages Size 1: N-1A/A Elkhorn Etf Trust HTML 580K 4: COVER ¶ Comment-Response or Cover Letter to the SEC HTML 36K 2: EX-99.(J) Consent of Independent Registered Public HTML 6K Accounting Firm 3: EX-99.(Q) Powers of Attorney HTML 26K
cover.htm |
111 West Monroe Street
T 312.845.3000
F 312.701.2361
|
1.
|
Please amend the powers of attorney filed for the trustees of the Registrant in order to relate to a specific filing in accordance with Rule 483(b) under the Securities Act.
|
2.
|
Please remove the discussion of capital expenditures as an indirect return of capital to investors.
|
|
Response: Pursuant to the staff’s request, we deleted the following sentences: “Capital expenditures are one of the ways in which management can provide return of capital to investors. Capital expenditures, which represent a company’s re-investment of revenues back into the company, may be viewed as indirect return of capital to investors because such activity may increase the overall value of the enterprise.”
|
3.
|
Please address in the prospectus the scenario in which the eligible universe of the Index (as defined in the Registration Statement) falls to less than 100 constituents.
|
|
Response: Pursuant to the staff’s request, we added the following sentence in the prospectus: “If, in a future period, the eligible universe of the Index falls below 100, the Index Provider will evaluate the methodology and make adjustments to the number of constituents in the Index accordingly.”
|
5.
|
Please add a risk factor discussing the disclosure on the Cover Page that “Shares of the Fund trade on the Exchange at market prices that may be below, at or above the Fund’s net asset value.”
|
|
Response: Pursuant to the staff’s request, we added the following risk factor: “Active Market Risk. Although the Shares are listed for trading on NASDAQ, there can be no assurance that an active trading market for the Shares will develop or be maintained. Shares trade on NASDAQ at market prices that may be below, at or above the Fund’s net asset value.”
|
6.
|
Please consider adding risk factors concerning investments in U.S. issuers and the management of the Fund.
|
|
Response: The Fund believes that each principal risk of investing in the Fund is disclosed in the Registration Statement filed herewith.
|
7.
|
Please disclose that, with respect to issuing and redeeming Shares, authorized participants must have entered into agreements with the Fund’s distributor.
|
|
Response: Pursuant to the staff’s request, we added a brief, bolded caption to each additional risk.
|
9.
|
Please expand the disclosure in connection with the following fundamental policy of the Fund: “(5) The Fund may not make loans, except as permitted under the 1940 Act and exemptive orders granted thereunder.”
|
|
Response: Pursuant to the staff’s request, we added the following sentence, which explains the restrictions as outlined under the 1940 Act: “For purposes of applying restriction (5) above, the Fund may not make loans to other persons, except through (i) the purchase of debt securities permissible under the Fund’s investment policies, (ii) repurchase agreements, or (iii) the lending of portfolio securities, provided that no such loan of portfolio securities may be made by the Fund if, as a result, the aggregate of such loans would exceed 33-1/3% of the value of the Fund’s total assets.”
|
|
Response: Pursuant to the staff’s request, we added the following sentence: “The Trust has not established a lead independent Trustee position.”
|
11.
|
Please update the page reference to the Fund’s Statement of Assets and Liabilities and accompanying Notes to Financial Statements.
|
This ‘N-1A/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 5/20/15 | CORRESP | ||
5/6/15 | ||||
4/28/15 | N-1A/A | |||
2/7/15 | ||||
1/13/15 | N-1A | |||
List all Filings |